These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10933661)

  • 21. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses.
    Guglick MA; MacAllister CG; Clarke CR; Pollet R; Hague C; Clarke JM
    Am J Vet Res; 1998 Apr; 59(4):458-63. PubMed ID: 9563631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of age and gender on pharmacokinetics of cefepime.
    Barbhaiya RH; Knupp CA; Pittman KA
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1181-5. PubMed ID: 1416818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies.
    Lodise TP; Rhoney DH; Tam VH; McKinnon PS; Drusano GL
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):223-30. PubMed ID: 16423490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of E. coli lipopolysaccharide induced fever on the plasma kinetics of cefepime in cross-bred calves.
    Pawar YG; Sharma SK
    Vet Res Commun; 2008 Feb; 32(2):123-30. PubMed ID: 17610035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefepime: a review.
    Van der Auwera P; Santella PJ
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():103-15. PubMed ID: 8150753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of cefepime in patients with respiratory tract infections.
    Kovarik JM; ter Maaten JC; Rademaker CM; Deenstra M; Hoepelman IM; Hart HC; Matzke GR; Verhoef J
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1885-8. PubMed ID: 2291655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits.
    Goudah A; Mouneir SM; Shim JH; Abd El-Aty AM
    J Vet Sci; 2006 Jun; 7(2):151-5. PubMed ID: 16645340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefepime versus cefpirome: the importance of creatinine clearance.
    Lipman J; Wallis SC; Boots RJ
    Anesth Analg; 2003 Oct; 97(4):1149-1154. PubMed ID: 14500173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of pharmacokinetic interaction between cefepime and amikacin in humans.
    Barbhaiya RH; Knupp CA; Pfeffer M; Pittman KA
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1382-6. PubMed ID: 1510431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.
    Reed MD; Yamashita TS; Knupp CK; Veazey JM; Blumer JL
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1783-7. PubMed ID: 9257761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetic profile of a new generation of parenteral cephalosporin.
    Rybak M
    Am J Med; 1996 Jun; 100(6A):39S-44S. PubMed ID: 8678096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
    Whited L; Grove M; Rose D; Rhodes NJ; Scheetz MH; O'Donnell JN; Neeb J; Thoele K; Jones DR; Lowe C; Moore D; Kiel PJ
    Pharmacotherapy; 2016 Sep; 36(9):1003-10. PubMed ID: 27496678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects.
    Barbhaiya RH; Knupp CA; Tenney J; Martin RR; Weidler DJ; Pittman KA
    J Clin Pharmacol; 1990 Oct; 30(10):900-10. PubMed ID: 2229450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables.
    Georges B; Conil JM; Seguin T; Dieye E; Cougot P; Decun JF; Lavit M; Samii K; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2008 Apr; 46(4):157-64. PubMed ID: 18397688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.
    Rhodes NJ; Grove ME; Kiel PJ; O'Donnell JN; Whited LK; Rose DT; Jones DR; Scheetz MH
    Int J Antimicrob Agents; 2017 Sep; 50(3):482-486. PubMed ID: 28668694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cyclosporine, a P-glycoprotein inhibitor, on the pharmacokinetics of cefepime in rat blood and brain: a microdialysis study.
    Chang YL; Chou MH; Lin MF; Chen CF; Tsai TH
    Life Sci; 2001 Jun; 69(2):191-9. PubMed ID: 11441909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of cefepime in the central nervous system of patients with external ventricular drains.
    Rhoney DH; Tam VH; Parker D; McKinnon PS; Coplin WM
    Pharmacotherapy; 2003 Mar; 23(3):310-4. PubMed ID: 12627928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.